TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10935148

Group type: EXPERIMENTAL
Intervention: Neuroleptanalgesia (0.025 mg fentanyl and 1.25 mg droperidol)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Morphine (10 mg initial dose, followed by 5 mg every 4 hours)
Number of subjects: 112
Study: 9167897

Group type: EXPERIMENTAL
Intervention: AvaII polymorphism of the apo CII gene
Number of subjects: 226

Group type: COMPARATOR
Intervention: apo E polymorphism
Number of subjects: 226
Study: 8459266

Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) plus folinic acid (FA)
Number of subjects: 150
Study: 3515526

Group type: EXPERIMENTAL
Intervention: Enteric-coated naproxen tablets (500 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Plain naproxen tablets (500 mg)
Number of subjects: 29
Study: 31409355

Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation combined with traditional bladder function training
Number of subjects: 91

Group type: COMPARATOR
Intervention: Traditional bladder training (Control)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation
Number of subjects: 91
Study: 30067488

Group type: EXPERIMENTAL
Intervention: Rapid atrial pacing during ablation lesions
Number of subjects: 20

Group type: COMPARATOR
Intervention: No pacing during ablation lesions
Number of subjects: 20
Study: 27107490

Group type: EXPERIMENTAL
Intervention: ICS plus theophylline 100 mg bid
Number of subjects: 70

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 70
Study: 25178899

Group type: EXPERIMENTAL
Intervention: Body-as-process video
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Body-as-object video
Number of subjects: 91

Group type: COMPARATOR
Intervention: Neutral video
Number of subjects: 91
Study: 22749428

Group type: EXPERIMENTAL
Intervention: Prostate intensity-modulated radiotherapy (IMRT)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Erectile tissue-sparing IMRT technique
Number of subjects: 94
Study: 20951305

Group type: EXPERIMENTAL
Intervention: 0.2-mm voxel resolution
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 0.3-mm voxel resolution
Number of subjects: 180

Group type: COMPARATOR
Intervention: Gutta-percha
Number of subjects: 180

Group type: COMPARATOR
Intervention: Cast-gold posts
Number of subjects: 180
Study: 17352751

Group type: EXPERIMENTAL
Intervention: Mepilex (Molnlycke Health Care AB)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Allevyn Hydrocellular (Smith & Nephew)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Both dressings
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Mepilex
Number of subjects: 156

Group type: COMPARATOR
Intervention: Allevyn
Number of subjects: 156
Study: 15649831

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (manual acupuncture at Y point on the neck, 4 sessions over 2 weeks)
Number of subjects: 326

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 326
Study: 11322870

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bisoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Celiprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carvedilol vs Metoprolol
Number of subjects: 0
Study: 9539185

Group type: EXPERIMENTAL
Intervention: Low-energy diet (4.2 MJ/d)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Low-energy diet + standardized physical exercise
Number of subjects: 121

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 121
Study: 7864327

Group type: EXPERIMENTAL
Intervention: Higher concentration of bupivacaine combined with fentanyl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower concentration of bupivacaine combined with fentanyl
Number of subjects: 0
Study: 2598986

Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (5 mg.h‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline infusion with caerulein (10‐40 ng.kg‐1.h‐1)
Number of subjects: 8
Study: 16115390

Group type: EXPERIMENTAL
Intervention: Theophylline 0.2 g twice a day for one month (group CA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No theophylline (group CB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy non-smokers (group H)
Number of subjects: 40
Study: 31418538

Group type: EXPERIMENTAL
Intervention: Rolapitant (single dose range, 9-180 mg)
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Rolapitant metabolite M19
Number of subjects: 482
Study: 28273591

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention for caregivers (initial sessions and monthly monitoring for 6 months)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention for caregivers
Number of subjects: 190
Study: 25591131

Group type: EXPERIMENTAL
Intervention: Off-axis elliptical training program
Number of subjects: 12
Study: 23701174

Group type: EXPERIMENTAL
Intervention: Large muscle group exercises first (LG-SM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Small muscle group exercises first (SM-LG)
Number of subjects: 16
Study: 21261971

Group type: EXPERIMENTAL
Intervention: Comprehensive treatment of MTrPs including manual compression, manual stretching, intermittent cold application, home exercises, and ergonomic advice.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comprehensive treatment of MTrPs.
Number of subjects: 0
Study: 19934922

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Reconstruction with a J-pouch
Number of subjects: 364

Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 364
Study: 16960170

Group type: EXPERIMENTAL
Intervention: Tomato extract (6TE)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tomato extract (2TE)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control supplements
Number of subjects: 90
Study: 14993543

Group type: EXPERIMENTAL
Intervention: Nutrient-enriched formula
Number of subjects: 474

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 474

Group type: COMPARATOR
Intervention: Breastfed
Number of subjects: 474
Study: 11726005

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (25-100 mg/d)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study: 9221017

Group type: EXPERIMENTAL
Intervention: Loratadine (second generation anti-histamine)
Number of subjects: 0
Study: 8422185

Group type: EXPERIMENTAL
Intervention: Idarubicin
Number of subjects: 2

Group type: COMPARATOR
Intervention: SM‐5887, KRN‐8602, ME‐2303
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: CI‐941
Number of subjects: 2
Study: 2889079

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (SK)
Number of subjects: 11712

Group type: COMPARATOR
Intervention: Control group (no SK)
Number of subjects: 11712
Study: 31043815

Group type: EXPERIMENTAL
Intervention: Co-created patient education material (pem)
Number of subjects: 574

Group type: COMPARATOR
Intervention: Expert-created patient education material (pem)
Number of subjects: 574
Study: 27141849

Group type: EXPERIMENTAL
Intervention: Cold counter-irritation (4°C to 22°C)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Chemical 'cold-like' counter-irritation with 40% L-menthol and 10% trans-cinnamaldehyde
Number of subjects: 13

Group type: COMPARATOR
Intervention: 5% doxepin (positive control)
Number of subjects: 13
Study: 23889649

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) training, 3 times per week for 11 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study: 21445242

Group type: EXPERIMENTAL
Intervention: SF-36 vitality scores at follow-up (mean of 64 weeks after stroke onset)
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Female sex, increasing age, lower mental health, and lower emotional role function scores
Number of subjects: 1080
Study: 19837254

Group type: EXPERIMENTAL
Intervention: Prophylactic paracetamol (3 doses every 6-8 hours in the first 24 hours)
Number of subjects: 459

Group type: COMPARATOR
Intervention: No prophylactic paracetamol
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Prophylactic paracetamol
Number of subjects: 459
Study: 16387819

Group type: EXPERIMENTAL
Intervention: Rhythm control
Number of subjects: 183

Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 183
Study: 12548508

Group type: EXPERIMENTAL
Intervention: Tacrolimus, 20 ng/mL, plus Plasma‐lyte A liver flush solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Plasma‐lyte A (placebo)
Number of subjects: 20
Study: 11460282

Group type: EXPERIMENTAL
Intervention: Cervitec varnish
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 24
Study: 9089994

Group type: EXPERIMENTAL
Intervention: Piggy-back technique
Number of subjects: 39

Group type: COMPARATOR
Intervention: Traditional method (venovenous bypass)
Number of subjects: 39
Study: 8406063

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 1.8% sezolamide
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 3512622

Group type: EXPERIMENTAL
Intervention: Fluspirilene (23 mg/week for men, 13 mg/week for women)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 40
Study: 30131313

Group type: EXPERIMENTAL
Intervention: Web-based survey with acceptance-facilitating intervention (AFI)
Number of subjects: 489

Group type: COMPARATOR
Intervention: Web-based survey without acceptance-facilitating intervention (AFI)
Number of subjects: 489
Study: 27585532

Group type: EXPERIMENTAL
Intervention: early goal-directed nutrition
Number of subjects: 200

Group type: COMPARATOR
Intervention: standard of care
Number of subjects: 200
Study: 24335446

Group type: EXPERIMENTAL
Intervention: Family presence during brain death evaluation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Not present during brain death evaluation (control)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Family presence (intervention)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Not present (control)
Number of subjects: 58
Study: 22575036

Group type: EXPERIMENTAL
Intervention: Omega-3 phosphatidylserine (PS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 20051119

Group type: EXPERIMENTAL
Intervention: Risk tailored intervention including educational intervention and counselling based on risk group assignment.
Number of subjects: 600

Group type: COMPARATOR
Intervention: Treatment as usual in primary care.
Number of subjects: 600
Study: 18978566

Group type: EXPERIMENTAL
Intervention: Paclitaxel 230 mg/m followed by cisplatin 75 mg/m on day 1 every 21 days, with granulocyte colony stimulating factor 5 microg/kg/d beginning on day 3 of each cycle
Number of subjects: 34
Study: 16343372

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) combined with other interventions
Number of subjects: 0
Study: 12436430

Group type: EXPERIMENTAL
Intervention: Decongestive lymphatic therapy (DLT) with adjunctive intermittent pneumatic compression (IPC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Decongestive lymphatic therapy (DLT) alone
Number of subjects: 50
Study: 11874940

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 7.5 mg pioglitazone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 15 mg pioglitazone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 30 mg pioglitazone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 45 mg pioglitazone
Number of subjects: 58
Study: 9521337

Group type: EXPERIMENTAL
Intervention: Intravenous ascorbate (vitamin C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7708954

Group type: EXPERIMENTAL
Intervention: Standard fractionation at 40 Gy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Standard fractionation at 50 Gy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Hypofractionation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard fractionation
Number of subjects: 32
Study: 2691013

Group type: EXPERIMENTAL
Intervention: SMS 201‐995 (50 micrograms subcutaneously 15 min before glucose intake)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: SMS 201‐995
Number of subjects: 8
Study: 29952675

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) 10 min at 10°C, n=10
Number of subjects: 23

Group type: COMPARATOR
Intervention: Passive recovery control (CON), n=13
Number of subjects: 23
Study: 28318550

Group type: COMPARATOR
Intervention: Circular stapling
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Triangulating stapling
Number of subjects: 100
Study: 26618470

Group type: EXPERIMENTAL
Intervention: Calcium Hydroxylapatite (CaHA) treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment until end of study)
Number of subjects: 30
Study: 23551070

Group type: EXPERIMENTAL
Intervention: 24 IU intranasal oxytocin (OXT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 47
Study: 21495524

Group type: EXPERIMENTAL
Intervention: Spiritual (SPIRIT) intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Educational (EDUC) intervention
Number of subjects: 100
Study: 18339449

Group type: EXPERIMENTAL
Intervention: ED observation unit care
Number of subjects: 153

Group type: COMPARATOR
Intervention: Routine inpatient care
Number of subjects: 153
Study: 16826364

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (400-1,200 IU per day) with calcium (800-1,500 mg per day)
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10000
Study: 12627044

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA), 5 mg/day for 14 days (days 12-25)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA), 10 mg/day for 14 days (days 12-25)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Dydrogesterone, 20 mg/day for 14 days (days 12-25)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Premenopausal women (group Y)
Number of subjects: 241
Study: 10615885

Group type: EXPERIMENTAL
Intervention: IUI alone
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: IUI after mild ovarian hyperstimulation
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 258

Group type: COMPARATOR
Intervention: IUI groups (both IUI alone and IUI after mild ovarian hyperstimulation)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: IUI
Number of subjects: 258
Study: 9174314

Group type: EXPERIMENTAL
Intervention: Clonidine 20 microg/h
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Clonidine 10 microg/h
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Clonidine 15 microg/h
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (bupivacaine and fentanyl)
Number of subjects: 90
Study: 8239616

Group type: EXPERIMENTAL
Intervention: High-dose mefloquine (25 mg/kg)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Conventional mefloquine (15 mg/kg)
Number of subjects: 139
Study: 29500116

Group type: EXPERIMENTAL
Intervention: Asset-based practices (intervention focusing on existing behavior)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Needs-based practices (intervention focusing on acquiring missing skills)
Number of subjects: 0
Study: 26572896

Group type: EXPERIMENTAL
Intervention: Cocaine
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Cannabis
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 24746163

Group type: EXPERIMENTAL
Intervention: Stereotype confirmation concerns
Number of subjects: 94
Study: 22961024

Group type: EXPERIMENTAL
Intervention: Daily disinfection of high-touch surfaces
Number of subjects: 0
Study: 21041348

Group type: EXPERIMENTAL
Intervention: Telehealth intervention (online multifamily psychoeducational therapy)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Usual care (treatment as usual)
Number of subjects: 55
Study: 18455252

Group type: EXPERIMENTAL
Intervention: Fractionated stereotactic boost (fSRT) of 20 Gy in 4 fractions
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional radiotherapy (control)
Number of subjects: 25
Study: 16052393

Group type: EXPERIMENTAL
Intervention: Dalteparin (low molecular weight heparin) administered immediately after cesarean section until mobilization
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (16 women without any other risk factors)
Number of subjects: 37
Study: 12480804

Group type: EXPERIMENTAL
Intervention: Single brand of ready-to-eat cereal with 2/3 C skim milk and a 100 Kcal portion of fruit for breakfast and as a replacement for either lunch or dinner for weeks 1 and 2, followed by a Volumetric diet for weeks 3 to 6.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Variety of ready-to-eat cereals for breakfast and as a replacement for either lunch or dinner for weeks 1 and 2, followed by a Volumetric diet for weeks 3 to 6.
Number of subjects: 106

Group type: COMPARATOR
Intervention: No dietary instruction during the six-week study.
Number of subjects: 106

Group type: COMPARATOR
Intervention: No intervention prior to adoption of the Volumetric diet for weeks 3 to 6.
Number of subjects: 106
Study: 8746864

Group type: EXPERIMENTAL
Intervention: Informed consent procedures
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Drug trials conducted by hospitals
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Signed consent form
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Right to withdraw from trial
Number of subjects: 64
Study: 1719924

Group type: EXPERIMENTAL
Intervention: 14-valent pneumococcal polysaccharide vaccine
Number of subjects: 0
Study: 6185014

Group type: EXPERIMENTAL
Intervention: Aortofemoral bypass
Number of subjects: 51

Group type: COMPARATOR
Intervention: Saphenous bypass
Number of subjects: 51
Study: 29943518

Group type: EXPERIMENTAL
Intervention: Enhanced Crisis Response Plan (E-CRP)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard Crisis Response Plan (treatment as usual)
Number of subjects: 97
Study: 30142573

Group type: EXPERIMENTAL
Intervention: Anodal transcranial Direct Current Stimulation of the right dorsolateral prefrontal cortex (preceding reencounter phase)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Anodal transcranial Direct Current Stimulation of the right dorsolateral prefrontal cortex (following reencounter phase)
Number of subjects: 118
Study: 26364288

Group type: EXPERIMENTAL
Intervention: Continuing clopidogrel 75 mg daily (extended‐dual antiplatelet therapy, DAPT, group)
Number of subjects: 1799

Group type: COMPARATOR
Intervention: Discontinuing clopidogrel (aspirin group)
Number of subjects: 1799

Group type: EXPERIMENTAL
Intervention: Continuing clopidogrel 75 mg daily (extended‐DAPT group)
Number of subjects: 1799
Study: 24476775

Group type: EXPERIMENTAL
Intervention: Block periodization training program (BP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional periodization program (TP)
Number of subjects: 24
Study: 23035060

Group type: EXPERIMENTAL
Intervention: Bilateral arm ischemic preconditioning (BAIPC), 5 brief cycles of ischemia followed by reperfusion, performed twice daily over 300 days.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (untreated), standard medical management only.
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Bilateral arm ischemic preconditioning (BAIPC)
Number of subjects: 68
Study: 18846366

Group type: EXPERIMENTAL
Intervention: Alcohol (low dose: 0.12 g/kg for women, 0.14 g/kg for men)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alcohol (high dose: 0.37 g/kg for women, 0.42 g/kg for men)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (for both alcohol and caffeine groups)
Number of subjects: 32
Study: 18437797

Group type: EXPERIMENTAL
Intervention: Immediate implants
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Early placed implants
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Immediate loading of implants
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 17
Study: 15149254

Group type: EXPERIMENTAL
Intervention: Speeded visual word naming
Number of subjects: 2428

Group type: EXPERIMENTAL
Intervention: Lexical decision performance
Number of subjects: 2428
Study: 11586014

Group type: EXPERIMENTAL
Intervention: Combination product of calcipotriol and betamethasone dipropionate
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate
Number of subjects: 25

Group type: COMPARATOR
Intervention: All treatments except for the vehicle
Number of subjects: 25

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 25
Study: 9676347

Group type: EXPERIMENTAL
Intervention: Sustained release pellets (500 mg theophylline)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intravenous infusion (350 mg theophylline over 8 h)
Number of subjects: 16
Study: 7734460

Group type: EXPERIMENTAL
Intervention: Experimental condition (once per month non‐random urine screen, counseling session and doctor visit, two times per month methadone pick up, a quarterly true random urine screen, and participation in a diversion control program)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control condition (staying under standard conditions for six months and then being transferred to the experimental condition for six months)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Study of Medical Maintenance (SMM) protocol 1 (once per month random urine screen, extending the experimental condition to two years)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Pilot subjects (N = 75)
Number of subjects: 130
Study: 2511776

Group type: EXPERIMENTAL
Intervention: Static pulmonary inflation during ECC, PEEP 5-10 cm H2O, F1O2 1.0
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-frequency ventilation during ECC, rate 10/min, PEEP 5 cm H2O, F1O2 1.0
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Medium-frequency ventilation during ECC, rate 120/min, PEEP 5 cm H2O, F1O2 1.0
Number of subjects: 30